Korean J Anat.  2007 Dec;40(4):297-310.

Gene Expression Changes of Drug-resistant Saos-2 Cells Induced by Anticancer Drug

Affiliations
  • 1Department of Biochemistry and Molecular Biology, College of Medicine, Yeungnam University, Daegu, Korea. seongyong@med.yu.ac.kr
  • 2Department of Anatomy, College of Medicine, Yeungnam University, Daegu, Korea.

Abstract

During the treatment of cancers, especially with anticancer drugs, the recurrence of cancer is the most important factor for survival rate. The most common cause of the recurrence is the resistance of cells to anticancer drugs. To explore and analyze the changes of gene expression during the induction of resistance by anticancer drugs in human osteogenic cancer cell line Saos-2. The drug resistance was induced with adriamycin, cisplatin or vincristine at 10(-7) M concentration of each and cDNA microarray was performed. Total RNA was purified from Saos-2, adriamycin-resistant (Saos-2AdR), cisplatin-resistant (Saos-2CpR) and vincristine-resistant (Saos-2VcR) and expressed genes were investigated with a Affymetrix Human HG-U133Plus2.0 GeneChip(TM). The genes of anticancer drug resistant cells that showed more than 2.5 fold expression change than Saos-2 were selected for differential expression. Four hundred seventeen genes were selected for Saos-2 vs Saos-2AdR. Two thousand five hundred thirty six genes were selected for Saos-2 vs Saos-2CpR. Two hundred twenty five genes were selected for Saos-2 vs Saos-2VcR. Eighty seven genes were selected for common differential expression. The results showed that many genes were changed in expression during the acquiring of resistance to anticancer drugs but most of genes were not in common among the three anticancer durg-resistant Saos-2. This means the different anticancer drug takes the different mechanism for acquiring resistance to anticancer drug even we use same cells.

Keyword

Anticancer durg-resistant; Adriamycin; cDNA microarray; Cisplatin; Gene expression; Vincristine; Saos-2

MeSH Terms

Cell Line
Cisplatin
Doxorubicin
Drug Resistance
Gene Expression*
Humans
Oligonucleotide Array Sequence Analysis
Recurrence
RNA
Survival Rate
Vincristine
Cisplatin
Doxorubicin
RNA
Vincristine
Full Text Links
  • KJA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr